Ning et al. revealed that CXCL8 regulated OXA-resistance of CRC cell lines by binding to CXCR2 and activating the AKT/MAPK/NF-κB signaling pathway [11]. The gene discussed is CXCL8; the disease is colorectal carcinoma.